Viewing Study NCT00603356

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:35 PM
Ignite Modification Date: 2026-01-03 @ 11:04 PM
Study NCT ID: NCT00603356
Status: COMPLETED
Last Update Posted: 2011-09-27
First Post: 2007-12-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I Study of OSI-930 and Erlotinib in Cancer Tumors
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GIST View
None Ovarian Cancer View
None Mesothelioma View
None Renal View
None Colorectal Cancer View
None Sarcoma View
None NSCLC View
None Cancer View